subject: UMLS:C1154269

subject_name: Eye drops brand of Tetrahydrozoline

object_name: cataract


subject: UMLS:C1154269

object_name: Cataract, CTCAE 3.0

tested_intervention: yes


subject: UMLS:C1154269

object_name: Cataract, CTCAE 5.0


subject: UMLS:C1154269

object_name: cataract on exam (physical finding)


subject: UNII:HOU4I0G29C

subject_name: Netazepide

object_name: peptic esophagitis


subject: UNII:HOU4I0G29C

object_name: Gastro-esophageal reflux disease with esophagitis


subject: UMLS:C1655276

subject_name: T-KI

object_name: Plexosarcoma


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: Advanced Malignant Solid Neoplasm

tested_intervention: unsure


subject: GTOPDB:13716

object_name: Advanced Gastroesophageal Junction Adenocarcinoma


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UNII:RB3U3A1S27


subject: UMLS:C4329329


subject: UMLS:C4329329


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: primary mediastinal large B-cell lymphoma


subject: CHEBI:32139

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:8382

subject_name: Prednisone

object_name: tuberculosis


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:AF75XOF6W3

object_name: Recurrent Glioblastoma


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:53221

subject_name: poly(ethyl methacrylate) macromolecule

object_name: varicose veins


subject: CHEBI:61371

subject_name: poly(ethyl methacrylate) polymer


subject: UniProtKB:P52651

subject_name: RHOX5_MOUSE Homeobox protein Rhox5 (sprot)


subject: PR:000014397

subject_name: homeobox protein Rhox5


subject: PR:000001890


subject: CHEBI:134703

subject_name: Fluciclovine (18F)

object_name: glioma


subject: CHEBI:134703

object_name: malignant glioma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Amputation Stumps


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Hepatic impairment


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: atrial fibrillation new onset


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Lung adenocarcinoma recurrent


subject: CHEBI:114785

object_name: Recurrent lung cancer


subject: CHEBI:114785

object_name: Recurrent Unspecified Lung Carcinoma


subject: CHEBI:114785

object_name: Stage IV Lung Cancer AJCC v7


subject: CHEBI:114785

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998

object_name: lung cancer


subject: CHEBI:75998

object_name: lung neoplasm


subject: CHEBI:76607

subject_name: Macitentan

object_name: interstitial lung disease


subject: CHEBI:76607

object_name: scleroderma


subject: CHEBI:76607

object_name: systemic sclerosis


subject: UMLS:C5964811


subject: CHEBI:78292

object_name: anemia


subject: UMLS:C3245083

subject_name: Electrolytic iron


subject: CHEBI:145373

subject_name: Pexidartinib

object_name: plexiform neurofibroma


subject: CHEBI:145373

object_name: acute promyelocytic leukemia


subject: CHEBI:145373

object_name: acute lymphoblastic leukemia


subject: CHEBI:135402

subject_name: Promestriene

object_name: hypospadias


subject: CHEBI:135402

object_name: Penile hypospadias


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: Vaginal Atrophy


subject: CHEBI:4903

object_name: Pain in female genitalia on intercourse


subject: UMLS:C5700426

subject_name: furmonertinib

object_name: neoplastic meningitis


subject: UMLS:C5700426

object_name: EGFR gene mutation


subject: CHEBI:84040

object_name: Vascular resistance (finding)


subject: CHEBI:84040

object_name: hypertension


subject: CHEBI:84040

object_name: Hypertension, CTCAE


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:36002


subject: CHEBI:36002


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:27881


subject: CHEBI:27881


subject: UNII:QUD44MBL5S

subject_name: TRELANSERIN

object_name: intermittent vascular claudication


subject: UMLS:C0962329


subject: CHEBI:37941

subject_name: Clopidogrel


subject: UNII:A7CGH459FN

subject_name: Ansofaxine

object_name: fibromyalgia


subject: UMLS:C5419263

subject_name: Toludesvenlafaxine


subject: UMLS:C4489845

subject_name: CANNABIDIOL OIL

object_name: Post-Operative Pain


subject: UNII:IYT6MP4NS9

object_name: aneurysm


subject: UNII:IYT6MP4NS9

object_name: CORONARY ARTERY DISEASE RISK FACTORS MULTIPLE


subject: UMLS:C4519750


subject: UMLS:C4519750


subject: UMLS:C5888373

object_name: non-small cell lung carcinoma


subject: UNII:M8R6ETA52F

subject_name: pirotinib


subject: UMLS:C4054177

subject_name: Pirotinib


subject: UNII:85KUE857XM

subject_name: SHR-1258 dimaleate


subject: UMLS:C5206643

subject_name: Pyrotinib Dimaleate


subject: CHEBI:33324

subject_name: strontium atom

object_name: bipolar depression


subject: CHEBI:4480

subject_name: diacetylmonoxime

object_name: Postoperative ileus


subject: UniProtKB:P0AEE8

subject_name: DMA_ECOLI DNA adenine methylase (sprot)


subject: PR:000022398

subject_name: DNA adenine methylase


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: sickle cell disease


subject: CHEBI:50648

subject_name: Alitretinoin

object_name: Kaposi Sarcoma


subject: CHEBI:50648

object_name: HIV infection


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: squamous cell lung carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:43755

subject_name: Lisinopril

object_name: prostate carcinoma


subject: CHEBI:43755

object_name: prostate cancer


subject: CHEBI:43755

object_name: Radiation Sickness


subject: CHEBI:43755

object_name: Urinary complication


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Funnel Chest


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:50634

object_name: Hypoxemia


subject: CHEBI:50634

object_name: Hypoxia, CTCAE


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: UNII:DA43GW06P1

subject_name: Methazolamide


subject: UNII:DA43GW06P1


subject: CHEBI:6822


subject: CHEBI:6822


subject: UNII:J7M4Z2D183

subject_name: Aroplatin

object_name: liver carcinoma


subject: UNII:J7M4Z2D183

object_name: neoplasm of esophagus


subject: UNII:J7M4Z2D183

object_name: colorectal neoplasm


subject: UNII:J7M4Z2D183

object_name: ovarian cancer


subject: UNII:J7M4Z2D183

object_name: ovarian neoplasm


subject: UNII:J7M4Z2D183

object_name: neoplasm


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: DRUGBANK:DB17319


subject: UMLS:C0125061

subject_name: L-NDDP


subject: UMLS:C0125061


subject: UMLS:C0125061


subject: UMLS:C0125061


subject: UMLS:C0125061


subject: UMLS:C0125061


subject: CHEBI:9123

subject_name: Sertraline

object_name: Alzheimer disease


subject: CHEBI:10642

subject_name: scyllo-inositol


subject: UMLS:C3641658

subject_name: Anti-ErbB3 Monoclonal Antibody REGN1400

object_name: cancer


subject: UMLS:C3641658


subject: CHEBI:49956

subject_name: Xenon

object_name: acute respiratory distress syndrome


subject: CHEBI:49956

object_name: acute lung injury


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Alzheimer disease type 1


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: plasma cell myeloma


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: degenerative myopia


subject: CHEBI:94782

subject_name: Cediranib

object_name: biliary tract neoplasm


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Nasopharyngeal squamous cell carcinoma stage IV


subject: CHEBI:71219

object_name: Nasopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:71219


subject: CHEBI:71219

object_name: Nasopharyngeal lymphoepithelioma stage IV


subject: CHEBI:42797

subject_name: Gabapentin

object_name: hyperemesis gravidarum


subject: CHEBI:107736

subject_name: Metoclopramide


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Vomiting, CTCAE


subject: CHEBI:46195

object_name: Vomiting


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Adult Systemic Anaplastic Large Cell Lymphoma


subject: UNII:7XL5ISS668

object_name: Systemic Anaplastic Large Cell Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: CHEBI:78432

subject_name: Ceritinib

object_name: ALK-positive anaplastic large cell lymphoma


subject: CHEBI:78432


subject: CHEBI:78432


subject: CHEBI:78432

object_name: anaplastic large cell lymphoma


subject: CHEBI:78432

object_name: CD30-Positive Neoplastic Cells Present


subject: CHEBI:39867

subject_name: Valproic acid

object_name: glycogen storage disease V


subject: CHEBI:4445

subject_name: Desflurane

object_name: Anaesthetic complication spinal


subject: CHEBI:9130

subject_name: Sevoflurane


subject: PUBCHEM.COMPOUND:9971980

subject_name: Tramal

object_name: Back Pain, CTCAE 5.0


subject: PUBCHEM.COMPOUND:9971980

object_name: Back pain


subject: PUBCHEM.COMPOUND:9971980

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:32250

subject_name: tramadol hydrochloride


subject: CHEBI:32250


subject: CHEBI:32250


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:46195


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:44915

subject_name: Propofol

object_name: acute kidney failure


subject: CHEBI:44915

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: inflammatory bowel disease 1


subject: CHEBI:7986

object_name: Crohn disease


subject: UMLS:C3273718

subject_name: Maveropepimut-S

object_name: Advanced cancer


subject: UMLS:C3273718

object_name: primary peritoneal carcinoma


subject: UMLS:C3273718

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C3273718

object_name: peritoneal carcinoma


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:143658


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Fever


subject: CHEBI:3181

object_name: Fever symptoms (finding)


subject: CHEBI:3181

object_name: Fever, CTCAE


subject: CHEBI:3181

object_name: traumatic encephalopathy


subject: CHEBI:3181

object_name: traumatic brain injury


subject: CHEBI:3181

object_name: intracerebral hemorrhage


subject: CHEBI:3181

object_name: subarachnoid hemorrhage


subject: CHEBI:3181

object_name: Subdural hemorrhage


subject: CHEBI:3181

object_name: Ischemic stroke


subject: CHEBI:8378

subject_name: Prednisolone

object_name: COPD exacerbation


subject: CHEBI:167574

subject_name: Semaglutide

object_name: coronary microvascular disorder


subject: CHEBI:167574

object_name: Arterial Stiffness


subject: CHEBI:167574

object_name: TNF receptor 1-associated periodic fever syndrome


subject: CHEBI:167574

object_name: frontometaphyseal dysplasia


subject: CHEBI:167574

object_name: frontometaphyseal dysplasia 1


subject: CHEBI:167574

object_name: facioscapulohumeral muscular dystrophy


subject: CHEBI:167574

object_name: facioscapulohumeral muscular dystrophy 1


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: PUBCHEM.COMPOUND:73151030


subject: CHEBI:16866

subject_name: alizarin


subject: UNII:4NJ842U6BZ

subject_name: azimexon


subject: PR:000022182

subject_name: regulatory protein AtoC


subject: CHEBI:90284

subject_name: pirazofurin


subject: CHEBI:74795

subject_name: Pro-Phe


subject: CHEBI:91825

subject_name: Dapt

object_name: Adherence To Medication Regime


subject: UNII:949B9ZMO7M

subject_name: Diaminopropanol tetraacetic acid


subject: PUBCHEM.COMPOUND:6438565


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:109549

subject_name: Ramelteon

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:109549

object_name: COPD, severe early onset


subject: UMLS:C0724588

subject_name: Recombinant Follicle Stimulating Hormone

object_name: Encounter due to In vitro fertilization


subject: CHEBI:63633

subject_name: Triptorelin


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: pneumonia


subject: UMLS:C0054066

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:3485

subject_name: Cefdinir


subject: CHEBI:3485


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Iron Overload


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: iron poisoning


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: Iron Overload, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: Increased reactive oxygen species production


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: Cooley's anemia


subject: CHEMBL.COMPOUND:CHEMBL2108391

object_name: beta thalassemia


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: CHEBI:44423


subject: UNII:CS4U38E731

subject_name: Nigella sativa oil


subject: UNII:CS4U38E731


subject: UNII:CS4U38E731


subject: UNII:CS4U38E731


subject: UNII:CS4U38E731


subject: UNII:CS4U38E731


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: CHEBI:25681


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:5ZB58O726V

subject_name: Leyk

object_name: myelosuppression


subject: UNII:5ZB58O726V

object_name: nasopharyngeal carcinoma


subject: UNII:5ZB58O726V

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0376721

subject_name: Leukogen


subject: UMLS:C0376721


subject: UMLS:C0376721


subject: PUBCHEM.COMPOUND:12443252

subject_name: Tauroursodeoxycholic acid

object_name: type 1 diabetes mellitus


subject: CHEBI:80774

subject_name: taurursodiol


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Supratentorial Glioblastoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:4875

subject_name: Etanercept

object_name: Tinnitus, Noise Induced


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: DRUGBANK:DB16592

subject_name: Frankincense

object_name: periodontal disorder


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:6427

subject_name: Leuprolide


subject: UNII:P76B05O5V6

subject_name: Relugolix


subject: UNII:P76B05O5V6

object_name: Prostate cancer recurrent


subject: PUBCHEM.COMPOUND:23709079

subject_name: Treximet

object_name: Menstrual migraine


subject: CHEBI:7476

subject_name: Naproxen


subject: DRUGBANK:DB18143

subject_name: MTL-CEBPA

object_name: hepatitis B


subject: DRUGBANK:DB18143

object_name: hepatitis C


subject: DRUGBANK:DB18143

object_name: liver carcinoma


subject: DRUGBANK:DB15853

subject_name: RUTI® Vaccine

object_name: pulmonary tuberculosis


subject: CHEBI:2950

subject_name: Azelastine

object_name: perennial allergic rhinitis


subject: CHEBI:4876

subject_name: Etacrynic acid

object_name: Fluid Overload


subject: CHEBI:4876

object_name: Hypervolemia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: 12-lead ECG QTc interval


subject: CHEBI:63611

object_name: respiratory syncytial virus infectious disease


subject: PUBCHEM.COMPOUND:134461434


subject: UNII:U4OI721DMD

subject_name: ZELICAPAVIR


subject: UNII:U4OI721DMD


subject: UMLS:C5909063

subject_name: Zelicapavir


subject: UMLS:C5909063


subject: UMLS:C5690454

object_name: autoimmune thrombocytopenia


subject: UMLS:C5690454

object_name: thrombocytopenia due to immune destruction


subject: UMLS:C5690454

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C5690454

object_name: SARS-CoV-2 acute respiratory disease


subject: UMLS:C5690454

object_name: thrombotic thrombocytopenic purpura


subject: UMLS:C5690454

object_name: adult lymphoma


subject: UMLS:C5690454

object_name: lymphoma


subject: UMLS:C5690454

object_name: pediatric lymphoma


subject: UMLS:C5690454

object_name: leukemia


subject: UMLS:C5690454

object_name: childhood leukemia


subject: UMLS:C5690454

object_name: plasma cell myeloma


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C5690452


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C3898831

object_name: pulmonary hypertension


subject: UMLS:C3898831

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C3898831

object_name: pulmonary arterial hypertension


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Intubation complication


subject: CHEBI:8802

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:8802

object_name: Obesity, CTCAE


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Rheumatic mitral stenosis with insufficiency


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:94534

subject_name: olanzapine

object_name: Hair-pulling


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: cardiovascular disorder


subject: CHEBI:9356

subject_name: Sultopride

object_name: BPSD


subject: CHEBI:9356

object_name: Alzheimer disease


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:64045


subject: CHEMBL.COMPOUND:CHEMBL3990003

subject_name: BALTALEUCEL-T

object_name: Hodgkin Disease


subject: CHEMBL.COMPOUND:CHEMBL3990003

object_name: Adult Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3990003

object_name: Childhood Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3990003


subject: CHEMBL.COMPOUND:CHEMBL3990003

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5557270

subject_name: EGFR/HER2 Inhibitor TAS2940

object_name: Childhood Solid Neoplasm


subject: UMLS:C5557270

object_name: Adult Solid Neoplasm


subject: UMLS:C5557270

object_name: Solid Neoplasm


subject: UMLS:C5557270

object_name: Childhood Breast Carcinoma


subject: UMLS:C5557270

object_name: breast carcinoma


subject: UMLS:C5557270

object_name: breast cancer


subject: UMLS:C5557270

object_name: non-small cell lung carcinoma


subject: UMLS:C5557270

object_name: glioblastoma


subject: UMLS:C5557270

object_name: Childhood Glioblastoma


subject: UMLS:C5557270

object_name: adult glioblastoma


subject: CHEBI:135474

subject_name: Intoplicine

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: Postoperative Pain, Acute


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:175901

object_name: peritoneal carcinoma


subject: CHEBI:63632

subject_name: Topotecan

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C1440044

subject_name: A,B

object_name: skin melanoma


subject: MESH:C056164

subject_name: fenugreek seed meal

object_name: Finding of lactation


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Poisoning by, adverse effect of and underdosing of other psychotropic drugs


subject: UNII:8LS9Y698WB

subject_name: LACTOBACILLUS ACIDOPHILUS CL1285

object_name: diarrhea


subject: UNII:8LS9Y698WB

object_name: rectal discharge diarrhea (physical finding)


subject: UNII:8LS9Y698WB

object_name: Diarrhea, CTCAE


subject: UNII:8LS9Y698WB

object_name: Clostridium infectious disease


subject: DRUGBANK:DB16541

subject_name: Lactobacillus casei


subject: DRUGBANK:DB16541


subject: DRUGBANK:DB16541


subject: DRUGBANK:DB16541


subject: CHEBI:45081

subject_name: Pentamidine

object_name: pancreatic neoplasm


subject: CHEBI:45081

object_name: exocrine pancreatic carcinoma


subject: CHEBI:45081

object_name: malignant pancreatic neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:94366

subject_name: itraconazole

object_name: Prostate cancer recurrent


subject: CHEBI:94366

object_name: Adenocarcinoma of the prostate stage II


subject: CHEBI:94366

object_name: Adenocarcinoma of the prostate stage III


subject: CHEBI:94366

object_name: Adenocarcinoma of the prostate stage I


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Gait impairment


subject: CHEBI:62995

subject_name: hexylene glycol


subject: CHEBI:62995

object_name: Parkinson disease


subject: PR:000010785

subject_name: diphosphomevalonate decarboxylase


subject: PR:000010785


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: actinic keratosis


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C5418091

subject_name: Fidasimtamab

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:64045

subject_name: Amisulpride

object_name: end stage renal failure


subject: CHEBI:64045

object_name: Chronic uremia


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: peritonitis


subject: UMLS:C0085297

object_name: Postoperative Complications


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: glucose metabolism disease


subject: PUBCHEM.COMPOUND:155543961

object_name: Abdominal obesity


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:167574

subject_name: Semaglutide


subject: CHEBI:167574

object_name: inherited lipid metabolism disorder


subject: CHEBI:167574


subject: CHEBI:119915

subject_name: Fentanyl

object_name: congenital heart disease


subject: CHEBI:119915

object_name: neurodevelopmental disorder


subject: CHEBI:119915

object_name: adverse effect to anesthesia


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:6015


subject: CHEBI:6015


subject: CHEBI:5613

subject_name: Haloperidol

object_name: glioblastoma


subject: CHEBI:5613

object_name: Brain Stem Glioblastoma


subject: CHEBI:5613

object_name: glioma susceptibility 1


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Delayed Emergence from Anesthesia


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C4733695

subject_name: Anti-LAG-3 Monoclonal Antibody Sym022

object_name: Childhood Solid Neoplasm


subject: UMLS:C4733695

object_name: Adult Solid Neoplasm


subject: UMLS:C4733695

object_name: Solid Neoplasm


subject: UMLS:C4733695

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4733695

object_name: Embolism, Tumor


subject: UMLS:C4733695

object_name: Neoplasm Metastasis


subject: UMLS:C4725832

subject_name: Anti-TIM-3 Monoclonal Antibody Sym023


subject: UMLS:C4725832


subject: UMLS:C4725832


subject: UMLS:C4725832


subject: UMLS:C4725832


subject: UMLS:C4725832


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)

object_name: Kinetic tremor


subject: CHEBI:131701

object_name: Parkinson disease


subject: CHEBI:681850

subject_name: Conivaptan

object_name: Hypervolemia


subject: CHEBI:681850

object_name: Euvolemia


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Lack of Expression of PD-L1


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Intraoperative Hemorrhage


subject: UNII:7DP3NTV15T

subject_name: BLEOMYCIN SULFATE

object_name: adult germ cell tumor


subject: UNII:7DP3NTV15T

object_name: germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Germ Cell Cancer


subject: UNII:7DP3NTV15T

object_name: malignant germ cell tumor


subject: UNII:7DP3NTV15T

object_name: Testicular yolk sac tumour stage III


subject: UNII:7DP3NTV15T

object_name: Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Testicular yolk sac tumour stage II


subject: UNII:7DP3NTV15T

object_name: Testicular embryonal carcinoma stage III


subject: UNII:7DP3NTV15T

object_name: Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Testicular choriocarcinoma stage III


subject: UNII:7DP3NTV15T

object_name: Testicular yolk sac tumour stage I


subject: UNII:7DP3NTV15T

object_name: Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


subject: UNII:7DP3NTV15T

object_name: Testicular embryonal carcinoma stage II


subject: UNII:7DP3NTV15T

object_name: Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Testicular choriocarcinoma stage II


subject: UNII:7DP3NTV15T

object_name: Testicular embryonal carcinoma stage I


subject: UNII:7DP3NTV15T

object_name: Testicular Mixed Choriocarcinoma and Teratoma


subject: UNII:7DP3NTV15T

object_name: Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: UNII:7DP3NTV15T

object_name: Testicular choriocarcinoma stage I


subject: UNII:7DP3NTV15T

object_name: Ovarian germ cell choriocarcinoma stage III


subject: UNII:7DP3NTV15T

object_name: Seminoma of testis, stage 1


subject: UNII:7DP3NTV15T

object_name: Ovarian germ cell choriocarcinoma stage II


subject: UNII:7DP3NTV15T

object_name: embryonal carcinoma


subject: UNII:7DP3NTV15T

object_name: Ovarian germ cell choriocarcinoma stage IV


subject: UNII:7DP3NTV15T

object_name: Ovarian germ cell choriocarcinoma stage I


subject: UNII:7DP3NTV15T

object_name: immature ovarian teratoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Testicular yolk sac tumour stage III


subject: CHEBI:31355

object_name: Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: Testicular yolk sac tumour stage II


subject: CHEBI:31355

object_name: Testicular embryonal carcinoma stage III


subject: CHEBI:31355

object_name: Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: Testicular choriocarcinoma stage III


subject: CHEBI:31355

object_name: Testicular yolk sac tumour stage I


subject: CHEBI:31355

object_name: Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Testicular embryonal carcinoma stage II


subject: CHEBI:31355

object_name: Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Testicular choriocarcinoma stage II


subject: CHEBI:31355

object_name: Testicular embryonal carcinoma stage I


subject: CHEBI:31355

object_name: Testicular Mixed Choriocarcinoma and Teratoma


subject: CHEBI:31355

object_name: Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:31355

object_name: Testicular choriocarcinoma stage I


subject: CHEBI:31355

object_name: Ovarian germ cell choriocarcinoma stage III


subject: CHEBI:31355

object_name: Seminoma of testis, stage 1


subject: CHEBI:31355

object_name: Ovarian germ cell choriocarcinoma stage II


subject: CHEBI:31355

object_name: Ovarian germ cell choriocarcinoma stage IV


subject: CHEBI:31355

object_name: Ovarian germ cell choriocarcinoma stage I


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular yolk sac tumour stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular yolk sac tumour stage II


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular embryonal carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular choriocarcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular yolk sac tumour stage I


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular embryonal carcinoma stage II


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular choriocarcinoma stage II


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular embryonal carcinoma stage I


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular Mixed Choriocarcinoma and Teratoma


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:2767

object_name: Testicular choriocarcinoma stage I


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian germ cell choriocarcinoma stage III


subject: PUBCHEM.COMPOUND:2767

object_name: Seminoma of testis, stage 1


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian germ cell choriocarcinoma stage II


subject: PUBCHEM.COMPOUND:2767

object_name: embryonal carcinoma


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian germ cell choriocarcinoma stage IV


subject: PUBCHEM.COMPOUND:2767

object_name: Ovarian germ cell choriocarcinoma stage I


subject: PUBCHEM.COMPOUND:2767

object_name: immature ovarian teratoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: Testicular yolk sac tumour stage III


subject: CHEBI:4911

object_name: Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Testicular yolk sac tumour stage II


subject: CHEBI:4911

object_name: Testicular embryonal carcinoma stage III


subject: CHEBI:4911

object_name: Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Testicular choriocarcinoma stage III


subject: CHEBI:4911

object_name: Testicular yolk sac tumour stage I


subject: CHEBI:4911

object_name: Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:4911

object_name: Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:4911

object_name: Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


subject: CHEBI:4911

object_name: Testicular embryonal carcinoma stage II


subject: CHEBI:4911

object_name: Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:4911

object_name: Testicular choriocarcinoma stage II


subject: CHEBI:4911

object_name: Testicular embryonal carcinoma stage I


subject: CHEBI:4911

object_name: Testicular Mixed Choriocarcinoma and Teratoma


subject: CHEBI:4911

object_name: Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:4911

object_name: Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:4911

object_name: Testicular choriocarcinoma stage I


subject: CHEBI:4911

object_name: Ovarian germ cell choriocarcinoma stage III


subject: CHEBI:4911

object_name: Seminoma of testis, stage 1


subject: CHEBI:4911

object_name: Ovarian germ cell choriocarcinoma stage II


subject: CHEBI:4911

object_name: Ovarian germ cell choriocarcinoma stage IV


subject: CHEBI:4911

object_name: Ovarian germ cell choriocarcinoma stage I


subject: CHEBI:3139

subject_name: bleomycin

object_name: adult germ cell tumor


subject: CHEBI:3139

object_name: germ cell tumor


subject: CHEBI:3139

object_name: Germ Cell Cancer


subject: CHEBI:3139

object_name: malignant germ cell tumor


subject: CHEBI:3139

object_name: Testicular yolk sac tumour stage III


subject: CHEBI:3139

object_name: Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Testicular yolk sac tumour stage II


subject: CHEBI:3139

object_name: Testicular embryonal carcinoma stage III


subject: CHEBI:3139

object_name: Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Testicular choriocarcinoma stage III


subject: CHEBI:3139

object_name: Testicular yolk sac tumour stage I


subject: CHEBI:3139

object_name: Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7


subject: CHEBI:3139

object_name: Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:3139

object_name: Testicular Mixed Choriocarcinoma and Embryonal Carcinoma


subject: CHEBI:3139

object_name: Testicular embryonal carcinoma stage II


subject: CHEBI:3139

object_name: Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:3139

object_name: Testicular choriocarcinoma stage II


subject: CHEBI:3139

object_name: Testicular embryonal carcinoma stage I


subject: CHEBI:3139

object_name: Testicular Mixed Choriocarcinoma and Teratoma


subject: CHEBI:3139

object_name: Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:3139

object_name: Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7


subject: CHEBI:3139

object_name: Testicular choriocarcinoma stage I


subject: CHEBI:3139

object_name: Ovarian germ cell choriocarcinoma stage III


subject: CHEBI:3139

object_name: Seminoma of testis, stage 1


subject: CHEBI:3139

object_name: Ovarian germ cell choriocarcinoma stage II


subject: CHEBI:3139

object_name: embryonal carcinoma


subject: CHEBI:3139

object_name: Ovarian germ cell choriocarcinoma stage IV


subject: CHEBI:3139

object_name: Ovarian germ cell choriocarcinoma stage I


subject: CHEBI:3139

object_name: immature ovarian teratoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Reperfusion Injury


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:16681698

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:16681698

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:16681698

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: alcohol withdrawal


subject: CHEBI:134689

subject_name: Rucaparib

object_name: pancreatic neoplasm


subject: CHEBI:134689

object_name: exocrine pancreatic carcinoma


subject: CHEBI:134689

object_name: malignant pancreatic neoplasm


subject: CHEBI:134689

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:139072

object_name: Childhood Breast Carcinoma


subject: CHEBI:139072

object_name: breast carcinoma


subject: CHEBI:139072

object_name: breast cancer


subject: CHEBI:139072

object_name: ovarian cancer


subject: CHEBI:139072

object_name: ovarian neoplasm


subject: CHEBI:139072

object_name: ovarian carcinoma


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:64816

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:4911


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: UMLS:C4723608

subject_name: Betamethasone Dipropionate Ointment

object_name: psoriasis vulgaris


subject: GTOPDB:12989

subject_name: toripalimab

object_name: thymic epithelial neoplasm


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEMBL.COMPOUND:CHEMBL2108446

subject_name: GUAR GUM

object_name: short bowel syndrome


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: obstructive sleep apnea syndrome


subject: CHEBI:17561

subject_name: Cysteine


subject: CHEBI:16163

subject_name: Carbocisteine


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Rubinstein-Taybi syndrome


subject: CHEBI:33704

subject_name: Amino acid

object_name: end stage renal failure


subject: CHEBI:33704

object_name: Chronic uremia


subject: UMLS:C0002520

subject_name: Amino Acids


subject: UMLS:C0002520


subject: UMLS:C2917660

subject_name: Amino Acid [EPC]


subject: UMLS:C2917660


subject: UMLS:C0353714

subject_name: Peritoneal dialysis solution (product)


subject: UMLS:C0353714


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Secondary Central Nervous System Lymphoma


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:91397

subject_name: Ibrutinib


subject: PUBCHEM.COMPOUND:21937662

subject_name: Isavuconazole

object_name: primary central nervous system lymphoma


subject: PUBCHEM.COMPOUND:21937662


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C1518386

subject_name: Non-Steroidal Aromatase Inhibitor

object_name: Carcinoma breast stage IV


subject: CHEBI:91419

object_name: neoplasm


subject: UMLS:C1541359


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Hepatic artery thrombosis


subject: CHEBI:68558

object_name: Complication of transplanted liver


subject: CHEBI:68558

object_name: Pediatric Disorder


subject: UMLS:C5455010

object_name: Non-Erosive Reflux Disease


subject: PUBCHEM.COMPOUND:23582788

subject_name: Tegoprazan


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Traumatic brain injury with brief loss of consciousness


subject: PUBCHEM.COMPOUND:24492

subject_name: Boric acid (HBO2)

object_name: traumatic encephalopathy


subject: PUBCHEM.COMPOUND:24492


subject: UMLS:C0030069

subject_name: Oxyhemoglobin


subject: UMLS:C0030069


subject: CHEBI:261649

subject_name: Bismuth subsalicylate

object_name: Well adult


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Thoracic Esophagus Adenocarcinoma


subject: CHEBI:31348

object_name: Cervical Esophagus Adenocarcinoma


subject: CHEBI:31348

object_name: Clinical Stage II Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage II Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage III Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31348

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:D99YVK4L0X

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Postinflammatory hyperpigmentation


subject: CHEBI:9168

subject_name: Sirolimus

object_name: brain stem infarction


subject: CHEBI:9168

object_name: intracerebral hemorrhage


subject: CHEBI:67272

subject_name: Perifosine

object_name: Recurrent Brain Neoplasm


subject: CHEBI:67272

object_name: mixed glioma


subject: CHEBI:67272

object_name: Childhood Mixed Glioma


subject: CHEBI:67272

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:67272

object_name: anaplastic oligodendroglioma


subject: CHEBI:67272

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:67272

object_name: anaplastic astrocytoma


subject: CHEBI:67272

object_name: glioblastoma


subject: CHEBI:67272

object_name: Childhood Glioblastoma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: CHEBI:79699


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:2285XW22DR

object_name: Non-small cell lung cancer stage IIIA


subject: UMLS:C2699335


subject: UMLS:C2699335


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: sleep apnea


subject: CHEBI:53760

object_name: Sleep Apnea, CTCAE


subject: UMLS:C5773278

object_name: Overweight


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: female infertility


subject: CHEBI:144903

object_name: Congenital anomaly of ovary


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: isolated optic nerve hypoplasia


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: schizophrenia


subject: UMLS:C1610033

subject_name: Interferon Alpha, Human

object_name: hepatitis C


subject: PR:000024938

subject_name: interferon alpha


subject: UMLS:C2911696

subject_name: Serotonin Reuptake Inhibitor [EPC]

object_name: Compulsion


subject: CHEBI:6931

subject_name: Midazolam

object_name: dental caries


subject: CHEBI:6931

object_name: Dental Caries, CTCAE


subject: CHEBI:6931

object_name: conscious sedation failure during procedure


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:8426

subject_name: Probenecid

object_name: kidney disorder


subject: CHEBI:8426

object_name: impaired renal function disease


subject: CHEBI:46261

subject_name: Phenylthiourea

object_name: Neuromuscular inhibition


subject: CHEBI:46261

object_name: Neuromuscular block, function


subject: UMLS:C4733228

subject_name: Oshadi D

object_name: Mesothelioma


subject: UMLS:C4733228

object_name: mesothelial neoplasm


subject: UMLS:C4733228

object_name: malignant mesothelioma


subject: UMLS:C4733229

subject_name: Oshadi R


subject: UMLS:C4733229


subject: UMLS:C4733229


subject: CHEBI:23965

subject_name: estradiol

object_name: Anorexia


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: Bone Resorption


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:10033

subject_name: Warfarin

object_name: Diabetes


subject: CHEBI:10033

object_name: diabetes mellitus


subject: CHEBI:75998

subject_name: Trametinib

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE

object_name: Pancreatic adenocarcinoma metastatic


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: Solid Neoplasm


subject: UMLS:C4085970


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: malignant soft tissue neoplasm


subject: CHEBI:151315

subject_name: Heparin

object_name: small cell lung carcinoma


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Pelvic Girdle Pain


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UNII:UH8E2N30I7

object_name: Dry age-related macular degeneration


subject: UMLS:C3830286

subject_name: Extended Release Flucytosine

object_name: glioblastoma


subject: UMLS:C3830286

object_name: Childhood Glioblastoma


subject: UMLS:C3830286

object_name: adult glioblastoma


subject: UMLS:C3830286

object_name: Supratentorial Glioblastoma


subject: UMLS:C3830286

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C3830286

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C3830286

object_name: anaplastic astrocytoma


subject: UMLS:C3830286

object_name: glioma susceptibility 1


subject: UMLS:C3830286

object_name: adult oligodendroglioma


subject: UMLS:C3830286

object_name: oligodendroglioma


subject: UMLS:C3830286

object_name: childhood oligodendroglioma


subject: UNII:DC4WO3WA4Q

subject_name: vocimagene amiretrorepvec


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: UNII:DC4WO3WA4Q


subject: CHEBI:75722

subject_name: Tramadol

object_name: Pruritus, CTCAE


subject: CHEBI:75722

object_name: Pruritus


subject: CHEBI:75722

object_name: dizziness


subject: CHEBI:75722

object_name: Vertigo as late effect of cerebrovascular disease


subject: CHEBI:75722

object_name: Vertigo, CTCAE


subject: CHEBI:75722

object_name: Nausea, CTCAE_5


subject: CHEBI:75722

object_name: Nausea


subject: CHEBI:75722

object_name: Nausea, CTCAE_3


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: leukopenia


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:33569

subject_name: noradrenaline

object_name: brain ischemia


subject: CHEBI:33569

object_name: cerebral infarction


subject: CHEBI:33569

object_name: subarachnoid hemorrhage


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:18357


subject: DRUGBANK:DB10510

subject_name: Brazil nut

object_name: Vegan diet


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate

object_name: breast neoplasm


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: osteoarthritis, hip


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: post operative nausea and vomiting


subject: UMLS:C5770463

subject_name: Hepcortespenlisimut-L

object_name: liver carcinoma


subject: UMLS:C5770463

object_name: liver cancer


subject: UMLS:C5770463

object_name: liver neoplasm


subject: UMLS:C5770463

object_name: Adult Liver Carcinoma


subject: UMLS:C5770463

object_name: Klatskin Tumor


subject: GTOPDB:13614

subject_name: givosiran

object_name: acute intermittent porphyria


subject: CHEBI:33325

subject_name: radium atom

object_name: clear cell renal carcinoma


subject: CHEBI:33325

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:80343

subject_name: Mecasermin

object_name: multiple sclerosis


subject: UMLS:C4310422


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: Blastoid Variant Mantle Cell Lymphoma


subject: UNII:06P3KLK2J8

object_name: Pleomorphic Variant Mantle Cell Lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:31174

subject_name: Adapalene

object_name: plantar wart


subject: UMLS:C5854362

subject_name: Anti-PD-L1/Anti-VEGF Bispecific Antibody Fusion Protein B1962

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5854362

object_name: cervical cancer


subject: UMLS:C5854362


subject: UMLS:C5854362

object_name: small cell lung carcinoma


subject: UMLS:C5854362

object_name: colorectal cancer


subject: UMLS:C5854362

object_name: colorectal carcinoma


subject: UMLS:C5854362

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:60918

subject_name: tegaserod

object_name: Diabetic gastropathy


subject: CHEBI:176724

subject_name: Etiracetam

object_name: brain aneurysm


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:2704

subject_name: Anastrozole

object_name: hypogonadism


subject: UMLS:C2986994

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C5963367

subject_name: Anti-B7-H3/Topoisomerase-1 Inhibitor Antibody-drug Conjugate BGB-C354

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4733069

object_name: Childhood Solid Neoplasm


subject: UMLS:C4733069

object_name: Adult Solid Neoplasm


subject: UMLS:C4733069

object_name: Solid Neoplasm


subject: UMLS:C4733069

object_name: lung cancer


subject: UMLS:C4733069

object_name: lung neoplasm


subject: UMLS:C4733069

object_name: lung carcinoma


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: pulmonary sarcoidosis


subject: CHEMBL.COMPOUND:CHEMBL2108696

subject_name: WHEAT BRAN

object_name: obesity


subject: UMLS:C3257534

subject_name: wheat bran extract


subject: UMLS:C1446591

subject_name: Wheat bran antigen


subject: CHEBI:4445

subject_name: Desflurane

object_name: Cognition disorders in old age


subject: CHEBI:44915

subject_name: Propofol


subject: UMLS:C1550506

subject_name: product - ParticipationType

object_name: rheumatoid arthritis


subject: UMLS:C2830202

object_name: acute lymphoblastic leukemia


subject: UMLS:C2830202

object_name: lymphoblastic lymphoma


subject: UMLS:C2830202

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C2830202

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C2830202

object_name: B-cell adult acute lymphocytic leukemia


subject: UMLS:C2830202

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:143658


subject: UMLS:C5205927

object_name: colorectal cancer


subject: UMLS:C5205927

object_name: colorectal carcinoma


subject: UMLS:C5205927

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: Familial hyperchylomicronemia syndrome


subject: CHEBI:74705

subject_name: Met-Leu

object_name: testosterone measurement


subject: CHEBI:74705

object_name: hematologic disorder


subject: CHEBI:74705

object_name: gender incongruence


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: adenomyosis


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride

object_name: periprosthetic joint infection


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: CHEBI:70714

subject_name: Teflaro

object_name: Complicated skin and soft tissue infection


subject: PUBCHEM.COMPOUND:72562361

subject_name: Ceftaroline fosamil


subject: CHEBI:36791

subject_name: Escitalopram

object_name: autism spectrum disorder


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: irritable bowel syndrome


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: prostate cancer


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UMLS:C3640943


subject: UMLS:C3640943


subject: CHEBI:8382

subject_name: Prednisone

object_name: immune reconstitution inflammatory syndrome


subject: UMLS:C0383956

subject_name: HBOC 201

object_name: Wounds and Injuries


subject: UNII:1XQE66T19H


subject: UNII:3JL137394Y

object_name: Iatrogenic Cushing's disease


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:2663

subject_name: Amiodarone

object_name: Sepsis


subject: CHEBI:2663

object_name: Sepsis, CTCAE


subject: CHEBI:2663

object_name: ventricular fibrillation


subject: CHEBI:2663

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:2663

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:2663

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:2663

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: CHEBI:2663

object_name: Rapid atrial fibrillation


subject: CHEBI:2663

object_name: septic shock


subject: CHEBI:8871

subject_name: Risperidone

object_name: Schizophrenia Spectrum and Other Psychotic Disorders


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: ovarian cancer


subject: CHEBI:94518

object_name: ovarian neoplasm


subject: CHEBI:94518

object_name: ovarian carcinoma


subject: CHEBI:36088

subject_name: thromboxanes A


subject: CHEBI:36088


subject: CHEBI:36088


subject: PUBCHEM.COMPOUND:10820564

subject_name: Fluciclovine

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:10820564

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:10820564

object_name: glioma


subject: PUBCHEM.COMPOUND:10820564

object_name: cancer


subject: PUBCHEM.COMPOUND:10820564

object_name: neoplasm


subject: UMLS:C4283866

subject_name: Fluciclovine f-18, diagnostic, 1 millicurie

object_name: metastatic malignant neoplasm in the brain


subject: UMLS:C4283866

object_name: glioblastoma


subject: UMLS:C4283866


subject: UMLS:C4283866


subject: UMLS:C4283866


subject: UMLS:C4283866


subject: UMLS:C4283866


subject: CHEBI:134703

subject_name: Fluciclovine (18F)


subject: CHEBI:134703


subject: UMLS:C4553796

subject_name: fluciclovine


subject: UMLS:C4553796


subject: UMLS:C4553796


subject: UMLS:C4553796


subject: UMLS:C4553796


subject: UMLS:C4553796


subject: UMLS:C4553796


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Post-thoracotomy pain syndrome


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:60802

subject_name: ropivacaine


subject: PUBCHEM.COMPOUND:135181440

subject_name: IRPAGRATINIB

object_name: liver carcinoma


subject: DRUGBANK:DB18732

subject_name: Irpagratinib


subject: UMLS:C0106006

object_name: Ketosis


subject: UMLS:C0106006

object_name: Ketoacidosis


subject: UMLS:C0106006

object_name: Hyperketonemia


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib

object_name: thyroid tumor


subject: UNII:CEGM9YBNGD

object_name: thyroid gland carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid gland follicular carcinoma


subject: UNII:CEGM9YBNGD

object_name: thyroid cancer, nonmedullary, 2


subject: UNII:CEGM9YBNGD

object_name: Thyroid cancer metastatic


subject: UNII:CEGM9YBNGD

object_name: Unresectable Thyroid Gland Carcinoma


subject: CHEBI:81567

subject_name: Thyrotropin


subject: CHEBI:81567


subject: CHEBI:81567

object_name: thyroid cancer


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: UMLS:C0876183

subject_name: Thyrogen


subject: UMLS:C0876183


subject: UMLS:C0876183


subject: MESH:C000603981

object_name: lymphoid system disorder


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: asthma


subject: UMLS:C5782775

subject_name: BUPivacaine 0.25% preservative-free injectable solution

object_name: Post-Operative Pain


subject: CHEBI:109549

subject_name: Ramelteon

object_name: brain injury


subject: PUBCHEM.COMPOUND:9821941

subject_name: lumateperone

object_name: pervasive developmental disorder


subject: PUBCHEM.COMPOUND:9821941

object_name: autism


subject: PUBCHEM.COMPOUND:9821941

object_name: autism spectrum disorder


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Stage IV Rectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: Rectal cancer stage IV


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Rectal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Rectal Cancer


subject: PUBCHEM.COMPOUND:1805

object_name: Colon cancer recurrent


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Colon Cancer AJCC v8


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Colon Cancer AJCC v6


subject: PUBCHEM.COMPOUND:1805

object_name: Stage IV Colon Cancer AJCC v7


subject: PUBCHEM.COMPOUND:1805

object_name: Malignant neoplasm of colon stage IV


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:132082

subject_name: Entinostat


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:132082


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Childhood Breast Carcinoma


subject: CHEBI:9168

object_name: breast carcinoma


subject: CHEBI:9168

object_name: breast cancer


subject: UMLS:C0076943

subject_name: Travasol

object_name: colorectal cancer


subject: UMLS:C0076943

object_name: colorectal carcinoma


subject: UMLS:C0076943

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0280081

subject_name: Amino Acid Injection


subject: UMLS:C0280081


subject: UMLS:C0280081


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: intracranial artery occlusion (diagnosis)


subject: UMLS:C5447457

subject_name: Inixaciclib

object_name: prostate carcinoma


subject: UMLS:C5447457

object_name: prostate cancer


subject: UMLS:C5447457

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C5447457

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5447457

object_name: prostate neoplasm


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: irritable bowel syndrome


subject: CHEBI:5775

subject_name: Hydralazine

object_name: ovarian cancer


subject: CHEBI:5775

object_name: ovarian neoplasm


subject: CHEBI:5775

object_name: ovarian carcinoma


subject: UNII:Q400352CM2


subject: UNII:Q400352CM2


subject: UNII:Q400352CM2


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Recurrent Kidney Wilms Tumor


subject: CHEBI:63605

object_name: Recurrent tumors of the Ewing's family


subject: CHEBI:63605

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:63605

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:63605

object_name: Recurrent Childhood Rhabdomyosarcoma


subject: CHEBI:63605

object_name: Childhood Embryonal Rhabdomyosarcoma


subject: CHEBI:63605

object_name: alveolar rhabdomyosarcoma


subject: CHEBI:63605

object_name: Childhood Synovial Sarcoma


subject: CHEBI:63605

object_name: Adult Synovial Sarcoma


subject: CHEBI:63605

object_name: Neuroblastoma recurrent


subject: CHEBI:63605

object_name: Osteosarcoma recurrent


subject: CHEBI:63605

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Anterior Cruciate Ligament Tear


subject: CHEMBL.COMPOUND:CHEMBL2108866

subject_name: STARCH

object_name: Regurgitation, Gastric


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: spinal cord injury


subject: UMLS:C5787220

subject_name: HM15211 (LONG-ACTING GLP-1/GIP/GLUCAGON TRIPLE AGONIST)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5787220

object_name: obesity


subject: UMLS:C5787220

object_name: Obesity, CTCAE


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: squamous cell carcinoma


subject: UNII:M89N0Q7EQR

object_name: cervical adenosquamous carcinoma


subject: UNII:M89N0Q7EQR

object_name: pancreatic adenosquamous carcinoma


subject: UNII:M89N0Q7EQR

object_name: adenosquamous carcinoma


subject: UNII:M89N0Q7EQR

object_name: esophageal adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: lung adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: cervical adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: adenocarcinoma


subject: UNII:M89N0Q7EQR

object_name: bile duct adenocarcinoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: gastric adenocarcinoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UMLS:C0717762

subject_name: Ethinyl Estradiol / norgestimate

object_name: acne


subject: CHEBI:231679

subject_name: ipilimumab

object_name: adenosquamous lung carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: kidney failure


subject: PUBCHEM.COMPOUND:66964417

object_name: Renal Failure, CTCAE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin


subject: PUBCHEM.COMPOUND:46783403


subject: UMLS:C5690696

subject_name: MitoQ

object_name: lower urinary tract symptom


subject: UMLS:C5690696

object_name: Urinary Urgency


subject: UNII:K27MHH614O

subject_name: mitoquinol


subject: UNII:K27MHH614O


subject: UMLS:C2830125

object_name: Cardiomegaly


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:38940

subject_name: Sunitinib

object_name: adrenal gland pheochromocytoma


subject: CHEBI:38940

object_name: pheochromocytoma


subject: CHEBI:38940

object_name: paraganglioma


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: Respiratory Sounds


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Myelodysplasia


subject: PR:000017019

object_name: Miller-Dieker lissencephaly syndrome


subject: PR:000017019

object_name: myoclonic dystonia 11


subject: PR:000017019

object_name: recurrent adult acute myeloid leukemia


subject: PR:000017019

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:YZS3R7LP44

subject_name: Palonosetron

object_name: melanoma


subject: UNII:IZT740JY57

object_name: Disseminated Malignant Neoplasm


subject: UNII:IZT740JY57

object_name: Embolism, Tumor


subject: UNII:IZT740JY57

object_name: Neoplasm Metastasis


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UMLS:C3501154


subject: UNII:5EZ01YDT5S

subject_name: Runcaciguat

object_name: diabetic retinopathy


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: Small cell lung cancer recurrent


subject: PUBCHEM.COMPOUND:16681698

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:94522


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UNII:39200FJ43J


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831948


subject: GTOPDB:13819

object_name: Childhood Solid Neoplasm


subject: GTOPDB:13819

object_name: Adult Solid Neoplasm


subject: GTOPDB:13819

object_name: Solid Neoplasm


subject: UMLS:C5237297


subject: UMLS:C5237297


subject: UMLS:C5237297


subject: UMLS:C0795649

subject_name: oat bran

object_name: rectal carcinoma


subject: UMLS:C0795649

object_name: rectal cancer


subject: UMLS:C0795649

object_name: Childhood Rectal Carcinoma


subject: CHEBI:33357

subject_name: hassium atom

object_name: Traumatic Shock


subject: CHEBI:74056

subject_name: His-Ser


subject: PR:000008437

subject_name: histidine ammonia-lyase


subject: CHEBI:48923

subject_name: erythromycin

object_name: bronchiectasis


subject: CHEBI:42355

subject_name: Erythromycin


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Advanced Dedifferentiated Liposarcoma


subject: UNII:6QVL057INT

object_name: Locally Advanced Dedifferentiated Liposarcoma


subject: UNII:6QVL057INT

object_name: Metastatic Dedifferentiated Liposarcoma


subject: UNII:6QVL057INT


subject: UNII:6QVL057INT

object_name: Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UNII:6QVL057INT

object_name: Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UMLS:C0751598

subject_name: Alferon

object_name: Stage III Renal Cell Cancer AJCC v8


subject: UMLS:C0751598

object_name: Stage III renal cell cancer


subject: UMLS:C0751598

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UMLS:C0751598

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0751598

object_name: clear cell renal carcinoma


subject: UMLS:C0751598

object_name: papillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: Catheter-associated urinary tract infection


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: RXCUI:151399

subject_name: Bactrim


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Systemic Vasculitis


subject: PUBCHEM.COMPOUND:146195299

subject_name: Golcadomide

object_name: Follicular lymphoma refractory


subject: PUBCHEM.COMPOUND:146195299

object_name: High grade B-cell lymphoma refractory


subject: PUBCHEM.COMPOUND:146195299

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:146195299

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:146195299

object_name: High grade B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:146195299

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:29HLR8Z5BR

subject_name: GOLCADOMIDE


subject: UNII:29HLR8Z5BR


subject: UNII:29HLR8Z5BR


subject: UNII:29HLR8Z5BR


subject: UNII:29HLR8Z5BR


subject: UNII:29HLR8Z5BR


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: PUBCHEM.COMPOUND:25127414

object_name: non-small cell lung carcinoma


subject: UNII:0ICW2LX8AS

subject_name: Bemcentinib


subject: CHEBI:84040

object_name: gestational diabetes


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:85990

subject_name: Panobinostat

object_name: metastatic melanoma


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: ichthyosis


subject: CHEBI:57586

subject_name: biotinate

object_name: nutritional biotin deficiency


subject: CHEBI:57586

object_name: biotinidase deficiency


subject: CHEBI:15956

subject_name: Biotin


subject: CHEBI:15956


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Prevention problem


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: chronic inflammatory demyelinating polyradiculoneuropathy


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UMLS:C5417823


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: gingival overgrowth


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:33349

subject_name: dubnium atom


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:133630

subject_name: His-Ala


subject: UniProtKB:P03456

subject_name: HEMA_I68A3 Hemagglutinin (sprot)


subject: UniProtKB:P03446

subject_name: HEMA_I76A2 Hemagglutinin (sprot)


subject: UniProtKB:A3DRP0

subject_name: HEMA_I96A2 Hemagglutinin (sprot)


subject: UniProtKB:A4K143

subject_name: HEMA_I54A2 Hemagglutinin (sprot)


subject: UniProtKB:B4URD6

subject_name: HEMA_I06A0 Hemagglutinin (sprot)


subject: UniProtKB:Q0A448

subject_name: hemagglutinin (Influenza A virus (strain A/Duck/Germany/1949 H10N7))


subject: UMLS:C4285347

subject_name: Ha Antibody


subject: UniProtKB:Q9WCD8

subject_name: HEMA_I61A1 Hemagglutinin (sprot)


subject: UniProtKB:P03453

subject_name: HEMA_I77AB Hemagglutinin (sprot)


subject: UniProtKB:A4U7A6

subject_name: HEMA_I51A0 Hemagglutinin (sprot)


subject: UniProtKB:P13103

subject_name: HEMA_I77AF Hemagglutinin (sprot)


subject: UniProtKB:P26136

subject_name: HEMA_I82A1 Hemagglutinin (sprot)


subject: UniProtKB:P07976

subject_name: HEMA_I83A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GBX7

subject_name: HEMA_I77AA Hemagglutinin (sprot)


subject: UniProtKB:P19698

subject_name: HEMA_I79A7 Hemagglutinin (sprot)


subject: UniProtKB:Q6LEJ4

subject_name: HEMA_I80A2 Hemagglutinin (sprot)


subject: UniProtKB:P03457

subject_name: HEMA_I66A1 Hemagglutinin (sprot)


subject: UniProtKB:A4GCL9

subject_name: HEMA_I35A3 Hemagglutinin (sprot)


subject: UniProtKB:Q9WFX3

subject_name: HEMA_I18A0 Hemagglutinin (sprot)


subject: UniProtKB:A4U6V2

subject_name: HEMA_I45A0 Hemagglutinin (sprot)


subject: UniProtKB:Q07FI5

subject_name: HEMA_I96A3 Hemagglutinin (sprot)


subject: UniProtKB:P03454

subject_name: HEMA_I33A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCK8

subject_name: HEMA_I43A0 Hemagglutinin (sprot)


subject: UniProtKB:P03448

subject_name: HEMA_I72A5 Hemagglutinin (sprot)


subject: UniProtKB:A4GCI6

subject_name: HEMA_I36A0 Hemagglutinin (sprot)


subject: UniProtKB:A4GCJ7

subject_name: HEMA_I80AA Hemagglutinin (sprot)


subject: UniProtKB:P04661

subject_name: HEMA_I56A2 Hemagglutinin (sprot)


subject: UniProtKB:Q0HD60

subject_name: HEMA_I40A0 Hemagglutinin (sprot)


subject: UniProtKB:P26139

subject_name: HEMA_I77A4 Hemagglutinin (sprot)


subject: UniProtKB:A4GCH5

subject_name: HEMA_I83A1 Hemagglutinin (sprot)


subject: CHEBI:6129

subject_name: Ketorolac

object_name: FEBRILE MORBIDITY


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: inherited bleeding disorder, platelet-type


subject: UNII:1C6V77QF41

object_name: blood platelet disease


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C4238109

subject_name: Inflectra

object_name: inflammatory bowel disease 1


subject: CHEBI:2677

subject_name: Augmentin

object_name: appendicitis


subject: CHEBI:2677

object_name: Appendicitis, CTCAE


subject: RXCUI:151392


subject: RXCUI:151392


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: PUBCHEM.COMPOUND:3467


subject: CHEBI:167661

object_name: Advanced cancer


subject: CHEBI:135207

subject_name: Clofedanol

object_name: cervical artery dissection


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: heart failure


subject: PUBCHEM.COMPOUND:521372

object_name: Heart Failure, CTCAE


subject: UMLS:C0772411

subject_name: potato starch

object_name: type 2 diabetes mellitus


subject: CHEBI:60802

subject_name: ropivacaine

object_name: carotid stenosis


subject: CHEBI:90620

subject_name: Vatalanib

object_name: pancreatic neoplasm


subject: CHEBI:90620

object_name: exocrine pancreatic carcinoma


subject: CHEBI:90620

object_name: malignant pancreatic neoplasm


subject: CHEBI:9123

subject_name: Sertraline

object_name: Disinhibition


subject: UMLS:C0885501

subject_name: Lac defloratum homeopathic preparation

object_name: hyperlipidemia


subject: UMLS:C0885501

object_name: arteriosclerosis disorder


subject: UMLS:C0885501

object_name: atherosclerosis


subject: UMLS:C0885501

object_name: Inflammation


subject: CHEBI:83766

subject_name: Olaparib

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C0662900

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: preeclampsia


subject: PUBCHEM.COMPOUND:2735

object_name: fetal growth restriction


subject: PUBCHEM.COMPOUND:2735

object_name: Fetal Growth Retardation, CTCAE


subject: PUBCHEM.COMPOUND:2735

object_name: gestational diabetes


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C1260201

subject_name: AMG 073

object_name: secondary hyperparathyroidism


subject: UMLS:C3819106

subject_name: Pedia-Lax Probiotic

object_name: Osteopenia


subject: UMLS:C5555041

subject_name: Emfizatamab

object_name: acute lymphoblastic leukemia


subject: CHEBI:47898

subject_name: Epirubicin

object_name: marginal zone lymphoma


subject: CHEBI:47898

object_name: MALT lymphoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Carcinoma liver resectable


subject: UMLS:C4547969

subject_name: apatinib mesylate


subject: GTOPDB:9758

subject_name: camrelizumab


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: PUBCHEM.COMPOUND:131704328

subject_name: Alginic acid

object_name: Reflux


subject: PUBCHEM.COMPOUND:131704328

object_name: dyspepsia


subject: PUBCHEM.COMPOUND:131704328

object_name: Dyspepsia, CTCAE


subject: CHEBI:58187

subject_name: alginate


subject: CHEBI:58187

object_name: Heartburn


subject: CHEBI:58187


subject: CHEBI:58187


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: UMLS:C0102137


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: cholecystolithiasis


subject: PUBCHEM.COMPOUND:6096882

object_name: gallstones


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: precancerous condition


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Coronavinae infectious disease


subject: CHEBI:136053

subject_name: Nemonoxacin

object_name: Decreased liver function


subject: UMLS:C4053585

subject_name: Hypoxia-activated Prodrug TH-4000

object_name: non-small cell lung carcinoma


subject: GTOPDB:12989

subject_name: toripalimab

object_name: esophageal cancer


subject: GTOPDB:12989

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:12989

object_name: neoplasm of esophagus


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy

object_name: Drug toxicity


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: PUBCHEM.COMPOUND:140987867

subject_name: Sulfonylurea

object_name: maturity-onset diabetes of the young type 1


subject: PUBCHEM.COMPOUND:140987867

object_name: maturity-onset diabetes of the young type 3


subject: PUBCHEM.COMPOUND:140987867

object_name: Childhood Diabetes Mellitus


subject: PUBCHEM.COMPOUND:140987867

object_name: type 1 diabetes mellitus


subject: CHEBI:76983

subject_name: N-sulfonylurea


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:76983


subject: CHEBI:26831

subject_name: N,N''-sulfonyldiurea


subject: CHEBI:26831


subject: CHEBI:26831


subject: CHEBI:26831


subject: MESH:D013453

subject_name: Sulfonylurea Compounds


subject: MESH:D013453


subject: MESH:D013453


subject: MESH:D013453


subject: UMLS:C3536898

subject_name: Sulfonylurea [EPC]


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: UMLS:C3536898


subject: CHEBI:3757

subject_name: Clonidine

object_name: Parkinson disease


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab

object_name: gastroesophageal cancer


subject: UMLS:C2733644

subject_name: Black Seed Oil

object_name: end stage renal failure


subject: UMLS:C2733644

object_name: Chronic uremia


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: acute stress disorder


subject: CHEBI:35523

subject_name: bronchodilator agent

object_name: COPD, severe early onset


subject: CHEBI:35523

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16302

object_name: Skin Wrinkling


subject: CHEBI:16302

object_name: Photodamaged skin


subject: CHEBI:50211

subject_name: retinol


subject: CHEBI:50211


subject: CHEBI:45479


subject: CHEBI:45479


subject: UMLS:C0087161

subject_name: all-trans-retinol


subject: UMLS:C0087161


subject: CHEBI:12777

subject_name: Vitamin A


subject: CHEBI:12777


subject: CHEBI:15367

subject_name: Tretinoin


subject: CHEBI:50648

subject_name: Alitretinoin


subject: CHEBI:50648


subject: CHEBI:17026

subject_name: Progesterone

object_name: Neonatal Complication


subject: CHEBI:17026

object_name: neonatal complications (history)


subject: UNII:7RPW6SU9SC

object_name: cholangiocarcinoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: childhood kidney neoplasm


subject: UMLS:C2981856

subject_name: BNC 105P

object_name: ovarian cancer


subject: UMLS:C2981856

object_name: ovarian neoplasm


subject: UMLS:C2981856

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Effects of chemotherapy


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Stage III Renal Cell Cancer AJCC v8


subject: CHEBI:201431

object_name: Stage III renal cell cancer


subject: CHEBI:201431

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5700219

object_name: clear cell renal carcinoma


subject: UMLS:C5700219

object_name: childhood kidney cell carcinoma


subject: UMLS:C5700219

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C5700219

object_name: Stage IV Renal Cell Cancer AJCC v8


subject: UMLS:C5700219

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219


subject: UMLS:C5700219

object_name: Papillary renal cell carcinoma type 2


subject: UMLS:C5700219

object_name: hereditary papillary renal cell carcinoma


subject: UMLS:C5700219

object_name: T-cell large granular lymphocyte leukemia


subject: UMLS:C5700219

object_name: Childhood Acute Lymphoblastic Leukemia in Remission


subject: UMLS:C5700219

object_name: Adult Acute Lymphoblastic Leukemia in Remission


subject: UMLS:C5700219

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C5700219

object_name: De Novo Myelodysplastic Syndrome


subject: UMLS:C4733671

object_name: Childhood Breast Carcinoma


subject: UMLS:C4733671

object_name: breast carcinoma


subject: UMLS:C4733671

object_name: breast cancer


subject: CHEBI:176304

subject_name: Azythromycin


subject: DRUGBANK:DB17625

object_name: Dyslipidemia


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:PQX0D8J21J

object_name: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:PQX0D8J21J

object_name: Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:PQX0D8J21J

object_name: Pathologic Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:PQX0D8J21J

object_name: KRAS Protein Variant


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Epileptic encephalopathy


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UNII:5OGS5K699E

subject_name: Merestinib

object_name: carcinoma of biliary tract


subject: UNII:5OGS5K699E

object_name: gallbladder carcinoma


subject: UNII:5OGS5K699E

object_name: non-Hodgkin lymphoma


subject: UNII:5OGS5K699E

object_name: cholangiocarcinoma


subject: UNII:C88817F47Y

object_name: Recurrent Endometrial Cancer


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: Childhood Soft Tissue Sarcoma


subject: MESH:C000629782

object_name: Adult Soft Tissue Sarcoma


subject: MESH:C000629782

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: MESH:C000629782

object_name: soft tissue sarcoma


subject: MESH:C000629782

object_name: Sarcoma G2


subject: MESH:C000629782

object_name: Sarcoma G3


subject: MESH:C000629782

object_name: Stage I Soft Tissue Sarcoma AJCC v7


subject: MESH:C000629782

object_name: Stage II Soft Tissue Sarcoma AJCC v7


subject: MESH:C000629782

object_name: Soft Tissue Sarcoma of the Trunk and Extremities


subject: MESH:C000629782

object_name: adult liposarcoma


subject: MESH:C000629782

object_name: liposarcoma


subject: MESH:C000629782

object_name: pediatric liposarcoma


subject: MESH:C000629782

object_name: leiomyosarcoma


subject: MESH:C000629782

object_name: Childhood Leiomyosarcoma


subject: MESH:C000629782

object_name: Adult Leiomyosarcoma


subject: MESH:C000629782

object_name: undifferentiated pleomorphic sarcoma


subject: MESH:C000629782

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:07730V90L6

object_name: Adult Soft Tissue Sarcoma


subject: UNII:07730V90L6

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:07730V90L6

object_name: soft tissue sarcoma


subject: UNII:07730V90L6

object_name: Sarcoma G2


subject: UNII:07730V90L6

object_name: Sarcoma G3


subject: UNII:07730V90L6

object_name: Stage I Soft Tissue Sarcoma AJCC v7


subject: UNII:07730V90L6

object_name: Stage II Soft Tissue Sarcoma AJCC v7


subject: UNII:07730V90L6

object_name: Soft Tissue Sarcoma of the Trunk and Extremities


subject: UNII:07730V90L6

object_name: adult liposarcoma


subject: UNII:07730V90L6

object_name: liposarcoma


subject: UNII:07730V90L6

object_name: pediatric liposarcoma


subject: UNII:07730V90L6

object_name: leiomyosarcoma


subject: UNII:07730V90L6

object_name: Childhood Leiomyosarcoma


subject: UNII:07730V90L6

object_name: Adult Leiomyosarcoma


subject: UNII:07730V90L6

object_name: undifferentiated pleomorphic sarcoma


subject: UNII:07730V90L6

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UNII:7TK323DLA0

subject_name: NOGAPENDEKIN ALFA INBAKICEPT

object_name: Childhood Synovial Sarcoma


subject: UNII:7TK323DLA0

object_name: Adult Synovial Sarcoma


subject: UNII:7TK323DLA0

object_name: synovial sarcoma


subject: UNII:7TK323DLA0

object_name: myxoid liposarcoma


subject: UNII:7TK323DLA0

object_name: round cell liposarcoma


subject: UNII:7TK323DLA0

object_name: myxoid/round cell liposarcoma


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: UMLS:C3658787


subject: PUBCHEM.COMPOUND:46874763

object_name: breast prosthesis; infection or inflammation


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:15365

subject_name: Aspirin

object_name: cardiac functional disturbances following surgery


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Prostate cancer recurrent


subject: CHEBI:177833

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:177833

object_name: Prostate cancer stage I


subject: CHEBI:177833

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:177833

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:177833

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:177833

object_name: Carcinoma of the prostate stage III


subject: CHEBI:177833

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:177833

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:177833

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: CHEBI:9144

subject_name: Silibinin

object_name: chronic obstructive pulmonary disease


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:7507

subject_name: Framycetin

object_name: type 2 diabetes mellitus


subject: CHEBI:7507

object_name: Diabetes


subject: CHEBI:7507

object_name: diabetes mellitus


subject: CHEBI:7507

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:7507

object_name: obesity


subject: CHEBI:7507

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403


subject: PUBCHEM.COMPOUND:46783403


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: malignant soft tissue neoplasm


subject: UNII:U6CKL88C8H

subject_name: GOCATAMIG

object_name: neuroendocrine carcinoma


subject: UMLS:C5446875

subject_name: Gocatamig


subject: GTOPDB:13850

subject_name: ifinatamab deruxtecan


subject: UNII:C6I0GC0GX5

subject_name: IFINATAMAB DERUXTECAN


subject: UMLS:C5417871


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: anemia due to chronic disorder


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Nicotine Addiction


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Alport syndrome


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: Menopause present (finding)


subject: CHEBI:8389

object_name: Menopause


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: PUBCHEM.COMPOUND:45357473


subject: CHEBI:74750

subject_name: Phe-Pro

object_name: esophageal squamous cell carcinoma


subject: PR:000014563

subject_name: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial


subject: CHEBI:73662

subject_name: Thr-Pro


subject: CHEBI:17347

subject_name: Testosterone


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UNII:580BNQ45EO

object_name: Recurrent Childhood Glioblastoma


subject: UNII:580BNQ45EO

object_name: Recurrent Glioblastoma


subject: CHEBI:6121

subject_name: Ketamine

object_name: Head Injury


subject: PUBCHEM.COMPOUND:46874763

object_name: complicated appendicitis


subject: CHEBI:177833

subject_name: Cilengitide

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:177833

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:177833

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:177833

object_name: Stage IV Prostate Cancer AJCC v8


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: UNII:B33561JJ61

subject_name: TELAGLENASTAT HYDROCHLORIDE

object_name: astrocytoma, IDH-mutant, grade 2


subject: UNII:B33561JJ61

object_name: astrocytoma, IDH-mutant, grade 3


subject: UMLS:C5418246

subject_name: Telaglenastat Hydrochloride


subject: UMLS:C5418246


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:34945

object_name: HIV infection


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:8776

subject_name: ranitidine

object_name: renal carcinoma


subject: CHEBI:8776

object_name: kidney neoplasm


subject: CHEBI:8776

object_name: kidney cancer


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: CHEBI:31905

subject_name: Nicorandil

object_name: myocardial infarction


subject: CHEBI:31905

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:31905

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: methamphetamine dependence


subject: CHEBI:71957

object_name: glioblastoma


subject: CHEBI:71957

object_name: Childhood Glioblastoma


subject: CHEBI:71957

object_name: adult glioblastoma


subject: UNII:60ES45KTMK

subject_name: Pilaralisib


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: CHEBI:124914

subject_name: Voxtalisib


subject: CHEBI:124914


subject: CHEBI:124914


subject: CHEBI:71958


subject: CHEBI:71958


subject: CHEBI:71958


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: DRUGBANK:DB05241


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: UMLS:C3642376


subject: CHEBI:135925

subject_name: Lisdexamfetamine

object_name: bulimia nervosa


subject: CHEBI:31596

subject_name: Febuxostat

object_name: kidney failure


subject: PUBCHEM.COMPOUND:85364158

subject_name: Duavee

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:85364158

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:85364158

object_name: breast cancer


subject: RXCUI:1441388

subject_name: bazedoxifene / estrogens, conjugated (USP) Oral Product


subject: RXCUI:1441388


subject: RXCUI:1441388


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: prostate neoplasm


subject: UMLS:C4053669

object_name: prostate cancer


subject: UMLS:C4053669


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UNII:DPT0O3T46P

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Ovarian cancer stage III


subject: UNII:DPT0O3T46P

object_name: Stage IIIC Ovarian Cancer


subject: UNII:DPT0O3T46P

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UNII:DPT0O3T46P

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C5222498

subject_name: Secukinumab Liquid Injection

object_name: metastatic melanoma


subject: UNII:DLG4EML025

subject_name: Secukinumab